These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 36200043)
41. A zebrafish model of PMM2-CDG reveals altered neurogenesis and a substrate-accumulation mechanism for N-linked glycosylation deficiency. Cline A; Gao N; Flanagan-Steet H; Sharma V; Rosa S; Sonon R; Azadi P; Sadler KC; Freeze HH; Lehrman MA; Steet R Mol Biol Cell; 2012 Nov; 23(21):4175-87. PubMed ID: 22956764 [TBL] [Abstract][Full Text] [Related]
42. Serum transferrin carrying the xeno-tetrasaccharide NeuAc-Gal-GlcNAc2 is a biomarker of ALG1-CDG. Bengtson P; Ng BG; Jaeken J; Matthijs G; Freeze HH; Eklund EA J Inherit Metab Dis; 2016 Jan; 39(1):107-14. PubMed ID: 26335155 [TBL] [Abstract][Full Text] [Related]
43. An engineered eukaryotic protein glycosylation pathway in Escherichia coli. Valderrama-Rincon JD; Fisher AC; Merritt JH; Fan YY; Reading CA; Chhiba K; Heiss C; Azadi P; Aebi M; DeLisa MP Nat Chem Biol; 2012 Mar; 8(5):434-6. PubMed ID: 22446837 [TBL] [Abstract][Full Text] [Related]
44. Analysis and metabolic engineering of lipid-linked oligosaccharides in glycosylation-deficient CHO cells. Jones MB; Tomiya N; Betenbaugh MJ; Krag SS Biochem Biophys Res Commun; 2010 Apr; 395(1):36-41. PubMed ID: 20331963 [TBL] [Abstract][Full Text] [Related]
45. Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophy. Yang AC; Ng BG; Moore SA; Rush J; Waechter CJ; Raymond KM; Willer T; Campbell KP; Freeze HH; Mehta L Mol Genet Metab; 2013 Nov; 110(3):345-351. PubMed ID: 23856421 [TBL] [Abstract][Full Text] [Related]
46. Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing. Timal S; Hoischen A; Lehle L; Adamowicz M; Huijben K; Sykut-Cegielska J; Paprocka J; Jamroz E; van Spronsen FJ; Körner C; Gilissen C; Rodenburg RJ; Eidhof I; Van den Heuvel L; Thiel C; Wevers RA; Morava E; Veltman J; Lefeber DJ Hum Mol Genet; 2012 Oct; 21(19):4151-61. PubMed ID: 22492991 [TBL] [Abstract][Full Text] [Related]
47. Postnatal changes in dolichol-pathway enzyme activities in rat liver. Oda-Tamai S; Kato S; Akamatsu N Biochem J; 1989 Jul; 261(2):371-5. PubMed ID: 2775223 [TBL] [Abstract][Full Text] [Related]
48. Severe, fatal multisystem manifestations in a patient with dolichol kinase-congenital disorder of glycosylation. Lieu MT; Ng BG; Rush JS; Wood T; Basehore MJ; Hegde M; Chang RC; Abdenur JE; Freeze HH; Wang RY Mol Genet Metab; 2013 Dec; 110(4):484-9. PubMed ID: 24144945 [TBL] [Abstract][Full Text] [Related]
49. A new role for dolichol isoform profile in the diagnostics of CDG disorders. Zdrazilova L; Kuchar L; Ondruskova N; Honzik T; Hansikova H Clin Chim Acta; 2020 Aug; 507():88-93. PubMed ID: 32289257 [TBL] [Abstract][Full Text] [Related]
50. Coupling of the dolichol-P-P-oligosaccharide pathway to translation by perturbation-sensitive regulation of the initiating enzyme, GlcNAc-1-P transferase. Gao N; Lehrman MA J Biol Chem; 2002 Oct; 277(42):39425-35. PubMed ID: 12176988 [TBL] [Abstract][Full Text] [Related]
51. Application of fluorophore-assisted carbohydrate electrophoresis for the study of the dolichol pyrophosphate-linked oligosaccharides pathway in cell cultures and animal tissues. Gao N Methods Mol Biol; 2006; 347():1-12. PubMed ID: 17072000 [TBL] [Abstract][Full Text] [Related]
52. Dysregulation of the Expression of Asparagine-Linked Glycosylation 13 Short Isoform 2 Affects Nephrin Function by Altering Its N-Linked Glycosylation. Esposito T; De Stefano G; Reccia MG; Di Lorenzo I; Napolitano F; Scalabrì F; Lombardi A; Saleem MA; Griffiths LR; Gianfrancesco F Nephron; 2017; 136(2):143-150. PubMed ID: 28178702 [TBL] [Abstract][Full Text] [Related]
53. Improvement of dolichol-linked oligosaccharide biosynthesis by the squalene synthase inhibitor zaragozic acid. Haeuptle MA; Welti M; Troxler H; Hülsmeier AJ; Imbach T; Hennet T J Biol Chem; 2011 Feb; 286(8):6085-91. PubMed ID: 21183681 [TBL] [Abstract][Full Text] [Related]
54. Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik. Grubenmann CE; Frank CG; Hülsmeier AJ; Schollen E; Matthijs G; Mayatepek E; Berger EG; Aebi M; Hennet T Hum Mol Genet; 2004 Mar; 13(5):535-42. PubMed ID: 14709599 [TBL] [Abstract][Full Text] [Related]
55. Identification and functional analysis of a defect in the human ALG9 gene: definition of congenital disorder of glycosylation type IL. Frank CG; Grubenmann CE; Eyaid W; Berger EG; Aebi M; Hennet T Am J Hum Genet; 2004 Jul; 75(1):146-50. PubMed ID: 15148656 [TBL] [Abstract][Full Text] [Related]
56. Mosaicism of the UDP-Galactose transporter SLC35A2 in a female causing a congenital disorder of glycosylation: a case report. Westenfield K; Sarafoglou K; Speltz LC; Pierpont EI; Steyermark J; Nascene D; Bower M; Pierpont ME BMC Med Genet; 2018 Jun; 19(1):100. PubMed ID: 29907092 [TBL] [Abstract][Full Text] [Related]